Chapter 13

Advanced Treatments for Parkinson’s Disease

For many years after diagnosis, most individuals with Parkinson’s disease achieve excellent symptom control with medications, regular exercise, and rehabilitation therapies. As the disease gradually progresses, however, some patients begin to experience increasing motor fluctuations, unpredictable “off” periods, troublesome dyskinesias, medication-resistant tremors, or side effects that cannot be adequately controlled by adjusting medications alone. When these problems begin interfering significantly with daily life, neurologists may recommend advanced therapies.

Advanced treatments do not cure Parkinson’s disease or stop its progression. Instead, they aim to improve symptom control, reduce medication-related complications, increase independence, and enhance overall quality of life. Careful patient selection is essential because not every advanced therapy is appropriate for every individual. Decisions are based on age, symptom pattern, cognitive function, overall health, lifestyle, and personal preferences.

A multidisciplinary team usually guides this process. Movement disorder specialists, neurosurgeons, nurses, neuropsychologists, rehabilitation therapists, speech-language pathologists, and other healthcare professionals work together to determine the most appropriate treatment plan for each patient.

When Are Advanced Therapies Considered?

Advanced therapies are generally considered when one or more of the following situations occur:

• Medication no longer provides consistent symptom control.
• “Off” periods become frequent or unpredictable.
• Dyskinesias interfere with daily activities.
• Tremor remains severe despite optimal medication.
• Medication side effects become difficult to manage.
• Daily functioning declines despite appropriate medical therapy.

Importantly, advanced treatment is not reserved only for the very late stages of Parkinson’s disease. Many patients benefit most when these therapies are introduced before severe disability develops.

Deep Brain Stimulation (DBS)

Among all advanced treatments, Deep Brain Stimulation (DBS) is the most widely used and extensively studied surgical therapy for Parkinson’s disease.

DBS involves implanting thin electrodes into carefully selected regions of the brain. These electrodes are connected by insulated wires beneath the skin to a small battery-powered device, often called a neurostimulator or brain pacemaker, which is implanted beneath the skin near the chest, similar to a cardiac pacemaker.

The neurostimulator delivers precisely controlled electrical impulses that modify abnormal brain activity responsible for many Parkinson’s symptoms.

Unlike older surgical procedures that permanently destroyed small areas of brain tissue, DBS is adjustable and reversible. Physicians can modify stimulation settings over time to optimize symptom control as the disease progresses.

Brain Targets for DBS

Several brain structures may serve as stimulation targets depending on the patient’s symptoms.

Subthalamic Nucleus (STN)

The subthalamic nucleus (STN) is the most commonly selected target worldwide.

STN stimulation often provides substantial improvement in:

• Tremor
• Bradykinesia
• Rigidity
• Motor fluctuations
• Dyskinesias (by allowing medication reduction)

Many patients can decrease their levodopa dosage after successful STN stimulation, reducing medication-related side effects.

Globus Pallidus Internus (GPi)

The globus pallidus internus (GPi) represents another excellent target.

GPi stimulation is particularly effective for:

• Dyskinesias
• Motor fluctuations
• Rigidity
• Tremor

Unlike STN stimulation, GPi stimulation usually requires less reduction in medication but often provides superior control of involuntary movements.

Ventral Intermediate Nucleus (VIM)

The ventral intermediate nucleus (VIM) of the thalamus is primarily used when severe tremor is the dominant symptom.

VIM stimulation improves tremor remarkably well but has less effect on rigidity, bradykinesia, or gait problems.

How DBS Surgery Is Performed

Before surgery, patients undergo extensive evaluation including neurological examination, brain MRI, neuropsychological testing, and detailed assessment of medication response.

During surgery, neurosurgeons use advanced imaging and computer-guided navigation to place electrodes with millimeter precision.

Some procedures are performed while the patient remains awake so that physicians can evaluate symptom improvement during electrode placement. Others are performed under general anesthesia using modern imaging guidance.

Following electrode implantation, the pulse generator is placed beneath the skin of the upper chest during the same operation or shortly afterward.

Programming begins several weeks later after surgical healing is complete.

Benefits of DBS

Numerous studies demonstrate that Deep Brain Stimulation can significantly improve quality of life.

Potential benefits include:

• Reduced tremor
• Less rigidity
• Improved walking
• Reduced “off” time
• Better control of dyskinesias
• Improved ability to perform daily activities
• Lower medication requirements in many patients
• Increased independence
• Better sleep in some individuals

Many patients experience several additional years of improved symptom control compared with medication adjustments alone.

Limitations of DBS

Although highly effective, DBS has limitations.

The procedure does not:

• Cure Parkinson’s disease.
• Prevent disease progression.
• Restore lost nerve cells.
• Improve symptoms that do not respond to levodopa.
• Completely eliminate the need for medication.

Symptoms such as balance problems, speech difficulties, swallowing impairment, and dementia may continue to progress because they often result from widespread disease beyond the specific brain circuits targeted by DBS.

Risks of DBS

Like every surgical procedure, DBS carries certain risks.

Possible complications include:

• Bleeding within the brain
• Stroke
• Infection
• Seizures
• Hardware malfunction
• Lead displacement
• Battery failure

Fortunately, serious complications are relatively uncommon when surgery is performed at experienced centers.

Programming-related side effects may include tingling sensations, speech changes, muscle contractions, balance disturbances, or mood changes. Most can be corrected by adjusting stimulation settings.

Who Is an Ideal Candidate?

The best candidates for DBS generally:

• Have confirmed Parkinson’s disease.
• Respond well to levodopa.
• Experience disabling motor fluctuations or dyskinesias.
• Do not have severe dementia.
• Have manageable psychiatric conditions.
• Are medically fit for surgery.

Advanced age alone is not necessarily a contraindication, although overall health becomes increasingly important.

Focused Ultrasound

A newer non-invasive treatment is Magnetic Resonance-guided Focused Ultrasound (MRgFUS).

Unlike DBS, focused ultrasound requires no surgical incision and no implanted hardware.

During treatment, hundreds of ultrasound beams pass harmlessly through the skull and converge at a precisely selected target deep within the brain. At the point of convergence, sufficient heat is generated to create a tiny therapeutic lesion.

MRI provides continuous guidance throughout the procedure, allowing physicians to monitor treatment in real time.

Focused ultrasound has shown excellent results for medication-resistant tremor and selected Parkinson’s symptoms.

Current limitations include:

• Usually treats only one side of the brain.
• Not reversible.
• Not adjustable after treatment.
• Long-term data remain more limited than for DBS.

Nevertheless, focused ultrasound represents an exciting alternative for carefully selected patients.

Continuous Levodopa Intestinal Infusion

Some individuals develop severe motor fluctuations despite optimized oral medication.

For these patients, continuous intestinal levodopa infusion offers another advanced treatment option.

A gel formulation of levodopa-carbidopa is continuously delivered directly into the small intestine through a tube connected to a portable pump.

Because medication enters the intestine continuously rather than in repeated tablets, dopamine levels remain much more stable.

Benefits often include:

• Reduced “off” time
• Fewer dyskinesias
• More predictable symptom control
• Improved daily functioning

Possible complications include tube blockage, infection, skin irritation, or pump malfunction.

Continuous Apomorphine Infusion

Another option involves continuous delivery of apomorphine, a dopamine agonist.

A small portable pump delivers medication beneath the skin through a fine needle similar to insulin therapy.

Continuous infusion reduces sudden “off” episodes and provides smoother symptom control throughout the day.

Side effects may include skin nodules, nausea, sleepiness, and low blood pressure.

Rescue Therapies for Sudden “Off” Episodes

Some patients experience sudden, unpredictable periods during which oral medication fails to work quickly enough.

Rescue treatments include:

• Injectable apomorphine
• Sublingual apomorphine film
• Inhaled levodopa powder

These medications work rapidly to restore movement during unexpected “off” episodes.

Lesioning Procedures

Before DBS became widely available, neurosurgeons treated Parkinson’s disease by creating small lesions within specific brain regions.

These procedures remain available in selected circumstances and include:

Pallidotomy

Pallidotomy targets the globus pallidus and primarily reduces dyskinesias, rigidity, and tremor.

Thalamotomy

Thalamotomy primarily improves severe tremor.

Today, lesioning procedures are performed less frequently because DBS offers greater flexibility through adjustable stimulation rather than permanent tissue destruction.

However, focused ultrasound has renewed interest in carefully targeted lesioning performed without open surgery.

Rehabilitation After Advanced Therapy

Advanced treatments do not replace rehabilitation.

Following DBS or other advanced procedures, patients often benefit from:

• Physical therapy
• Occupational therapy
• Speech therapy
• Swallowing evaluation
• Balance training
• Exercise programs

These therapies maximize the benefits of surgical treatment and promote long-term independence.

Battery Replacement and Follow-Up

The neurostimulator used in DBS requires periodic battery replacement.

Traditional batteries typically last three to five years, depending on stimulation settings.

Rechargeable systems may function for ten to fifteen years before replacement becomes necessary, provided patients recharge them regularly at home.

Regular follow-up appointments allow neurologists to:

• Adjust stimulation settings.
• Optimize medication.
• Monitor disease progression.
• Address new symptoms.
• Check hardware function.

Programming sessions may continue for several months after surgery until the optimal balance between symptom control and side effects is achieved.

Choosing the Right Advanced Therapy

Selecting among advanced treatments requires careful consideration.

Factors influencing treatment choice include:

• Age
• General health
• Cognitive function
• Dominant symptoms
• Response to levodopa
• Personal preferences
• Lifestyle
• Occupation
• Availability of specialized centers

There is no universally “best” treatment. The most appropriate therapy is the one that best addresses the individual’s specific needs while minimizing risk.

Emerging Technologies

Research into advanced Parkinson’s therapies continues at an extraordinary pace.

Several promising innovations are under investigation.

Adaptive Deep Brain Stimulation

Traditional DBS provides continuous stimulation regardless of symptom severity.

Adaptive DBS uses real-time brain signals to automatically adjust stimulation according to the patient’s current needs.

This approach may improve symptom control while reducing side effects and extending battery life.

Closed-Loop Brain Stimulation

Scientists are developing fully automated systems capable of continuously monitoring brain activity and adjusting stimulation without physician intervention.

These intelligent systems may provide more natural symptom control in the future.

Gene Therapy

Experimental gene therapy seeks to deliver beneficial genes directly into targeted brain regions.

Potential goals include:

• Increasing dopamine production
• Protecting surviving neurons
• Slowing disease progression

Several clinical trials are currently evaluating these approaches.

Stem Cell Therapy

Researchers are investigating transplantation of dopamine-producing cells derived from stem cells.

The long-term goal is to replace neurons lost during Parkinson’s disease and restore dopamine production naturally.

Although still experimental, early research has shown encouraging results.

Neuroprotective Therapies

Scientists continue searching for treatments capable of protecting neurons before irreversible damage occurs.

Potential strategies include:

• Anti-inflammatory drugs
• Alpha-synuclein antibodies
• Mitochondrial protective agents
• Growth factors
• Immune therapies

If successful, these treatments could fundamentally change Parkinson’s disease management by slowing or preventing progression.

Living Well After Advanced Treatment

Many individuals experience substantial improvement following advanced therapy, allowing renewed participation in work, travel, hobbies, family activities, and exercise.

However, realistic expectations remain important.

Advanced treatments improve symptoms but do not eliminate the need for healthy living.

Patients continue benefiting from:

• Regular exercise
• Balanced nutrition
• Medication adherence
• Mental stimulation
• Social engagement
• Adequate sleep
• Stress management
• Ongoing medical follow-up

Advanced therapies represent one of the greatest achievements in modern Parkinson’s disease care. They have transformed the lives of thousands of patients who previously had limited treatment options. As technology continues to evolve, future therapies promise even greater precision, fewer side effects, and the possibility of slowing or even preventing disease progression.

In the next chapter, we will explore physical therapy, occupational therapy, speech therapy, and rehabilitation, focusing on practical strategies that help individuals with Parkinson’s disease maintain mobility, independence, communication, and quality of life throughout every stage of the condition.